Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

US Patent 12435130 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electronic device comprising display module2025
Semiconductor package including image sensor chip, transparent substrate, and jo2025
Tray support structure and electronic device including the same2025
Anti-family with sequence similarity 19, member A5 antibodies and method of use 2025
Use of anti-family with sequence similarity 19, member A5 antibodies for the tre2024
Pharmaceutical use of FAM19A5 involved in regulating gliogenesis2023
Pharmaceutical use of FAM19A5 involved in regulating gliogenesis2023
Immunomodulatory composition comprising lactobacillus-derived extracellular vesi2023
Semiconductor package including image sensor chip, transparent substrate, and jo2023
Use of anti-FAM19A5 antibodies for treating cancers2023
Anti-family with sequence similarity 19, member A5 antibodies and method of use 2022
Agonist of spexin-based galanin type 2 receptor and use thereof2022